Tuomo Laitinen

2.4k citations
90 papers · 1.8k indexed · h-index 26
Topics
Cannabis and Cannabinoid Research (11 papers)HIV Research and Treatment (7 papers)Receptor Mechanisms and Signaling (7 papers)

In The Last Decade

Tuomo Laitinen

86 papers receiving 1.8k citations

Peers

Tuomo Laitinen
Comparison fields: 5 of 105
  • Molecular Biology 970
  • Organic Chemistry 354
  • Pharmacology 278
  • Computational Theory and Mathematics 193
  • Oncology 150
Replace Jianbin Zhang with:
Jianbin Zhang China
Lorraine M. Deck United States
Marina Ignatushchenko United States
Rilei Yu China
Lucy A. Hunsaker United States
Mohamed Touaibia Canada
José Antonio Encinar Spain
Rosanna Filosa Italy
Wannian Zhang China
Xu Shen China
Tuomo Laitinen relative to Jianbin Zhang China Jianbin Zhang's profile →
Citations per field
00.5×1.6×
Jianbin Zhang · 1×
Citations per year

Countries citing papers authored by Tuomo Laitinen

Since Specialization
Citations

This map shows the geographic impact of Tuomo Laitinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuomo Laitinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuomo Laitinen more than expected).

Fields of papers citing papers by Tuomo Laitinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuomo Laitinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuomo Laitinen. The network helps show where Tuomo Laitinen may publish in the future.

Co-authorship network of co-authors of Tuomo Laitinen

This figure shows the co-authorship network connecting the top 25 collaborators of Tuomo Laitinen. A scholar is included among the top collaborators of Tuomo Laitinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuomo Laitinen. Tuomo Laitinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 2
4 6
5 0
6 9
7 15
8 1
9 29
10 11
11 32
12 23
13 20
14 10
15 35
16 21
17 85
18 109
19 7
20 13

About Tuomo Laitinen

Tuomo Laitinen is a scholar working on Virology, Pharmacology and Molecular Biology, having authored 90 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (11 papers), HIV Research and Treatment (7 papers) and Receptor Mechanisms and Signaling (7 papers). The work is most often cited by research in Geriatrics and Gerontology (91 citations), Toxicology (60 citations) and Pharmacology (278 citations). Tuomo Laitinen has collaborated with scholars based in Finland, United States and Germany. Frequent co-authors include Antti Poso, Christopher R. M. Asquith, Juha Rouvinen, Tapio Nevalainen, Juha R. Savinainen, Jarmo T. Laitinen, Dina Navia‐Paldanius, Mikael Peräkylä, Teija Parkkari and Michael P. East. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Analytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026